spacer
spacer

PDBsum entry 6bb4

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Immune system PDB id
6bb4

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
211 a.a.
216 a.a.
Ligands
ILE-VAL-TYR-LYS-
SEP-PRO-VAL
×3
PO4 ×3
Waters ×874
PDB id:
6bb4
Name: Immune system
Title: Fab/epitope complex of mouse monoclonal antibody c5.2 targeting a phospho-tau epitope.
Structure: Mouse monoclonal antibody c5.2 fab light chain. Chain: l, m, n. Mouse monoclonal antibody c5.2 fab heavy chain. Chain: h, i, j. Microtubule-associated protein tau. Chain: p, q, r. Synonym: neurofibrillary tangle protein,paired helical filament-tau, phf-tau. Engineered: yes
Source: Mus musculus. Organism_taxid: 10090. Synthetic: yes. Homo sapiens. Human. Organism_taxid: 9606
Resolution:
2.10Å     R-factor:   0.218     R-free:   0.270
Authors: J.E.Chukwu,X.-P.Kong
Key ref: J.E.Chukwu et al. (2018). Tau Antibody Structure Reveals a Molecular Switch Defining a Pathological Conformation of the Tau Protein. Sci Rep, 8, 6209. PubMed id: 29670132
Date:
16-Oct-17     Release date:   02-May-18    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
No UniProt id for this chain
Struc: 211 a.a.
Protein chains
No UniProt id for this chain
Struc: 216 a.a.
Key:    Secondary structure

 

 
Sci Rep 8:6209 (2018)
PubMed id: 29670132  
 
 
Tau Antibody Structure Reveals a Molecular Switch Defining a Pathological Conformation of the Tau Protein.
J.E.Chukwu, J.T.Pedersen, L.Ã.˜.Pedersen, C.Volbracht, E.M.Sigurdsson, X.P.Kong.
 
  ABSTRACT  
 
Tau antibodies have shown therapeutic potential for Alzheimer's disease and several are in clinical trials. As a microtubule-associated protein, tau relies on dynamic phosphorylation for its normal functions. In tauopathies, it becomes hyperphosphorylated and aggregates into toxic assemblies, which collectively lead to neurodegeneration. Of the phospho-epitopes, the region around Ser396 has received particular attention because of its prominence and stability in tauopathies. Here we report the first structure of a monoclonal tau antibody in complex with the pathologically important phospho-Ser396 residue. Its binding region reveals tau residues Tyr394 to phospho-Ser396 stabilized in a β-strand conformation that is coordinated by a phospho-specific antigen binding site. These details highlight a molecular switch that defines this prominent conformation of tau and ways to target it. Overall, the structure of the antibody-antigen complex clarifies why certain phosphorylation sites in tau are more closely linked to neurodegeneration than others.
 

 

spacer

spacer